This website is intended for an international audience. To view your own country’s website if available, please select your country from the list provided.
Close
Close
Close
Close
Close
Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

Close

Theramex News

13 December 2021

Elaine Okpurhe, new Business Development Senior Director at Theramex

Theramex is delighted to announce the appointment of Elaine Okpurhe as Senior Director – Business Development, effective on 1st January 2022.

“With this appointment, Theramex shows its commitment to strategic Business Development as growth engine particularly as the Company enters consumer health. Elaine is the right person to lead our business development strategy and execution”, says Theramex CEO, Robert Stewart.

Elaine has been a Theramex consultant since March 2019 working alongside the BD team. Elaine has been pivotal in Theramex’s M&A transactions to date including the acquisition of Systen®/Evorel®. Prior to joining Theramex, Elaine held corporate roles at GE Healthcare, where she was responsible for business development transactions across the company’s $20 billion revenue healthcare businesses, and at Citi in investment and corporate banking.  Elaine holds a Master of Engineering degree from Imperial College, London.

23 December 2021

Theramex announces an agreement with Enzene Biosciences Limited for the development and commercialisation of Tocilizumab, a biosimilar for the treatment of rheumatoid arthritis

Read more

9 December 2021

Theramex Names Camilla Harder Hartvig As New Chief Commercial Officer

Read more